US FDA Approves Pfizer COVID-19 Vaccine for Emergency Use



[ad_1]

The United States Food and Drug Administration (FDA) announced that it allows the emergency use of the COVID-19 vaccine, which is a joint production of the companies Pfizer and Biontech.

The FDA said the vaccine could be given to people over the age of 16. The vaccine will be administered first to healthcare professionals. The United States government said distribution of the vaccine will begin immediately.

The president of the United States, Donald Trump, announced in a video message that he posted on his Twitter account that the first vaccine will be made in less than 24 hours.

Last week, deaths from Covid-19 in the country reached a record level, exceeding 3,000 a day. The vaccine developed by Biontech and advertised as 95% effective is predicted to prevent the disease.

NTV Washington representative Hüseyin Günay explained the details of the vaccine approval on the NTV broadcast. Gunay said: “The case of the corona virus in the US exceeds 15 million. The FDA has continued its evaluations of this vaccine for the last month. The vaccine was successful in clinical trials during the week. This was the first vaccine in the country to be approved against the corona virus. “The vaccine will be administered first to health workers, emergency medical teams and health officials who are housed in nursing homes. Starting in mid-March, everyone in the US will have access to the vaccine. The vaccine will be free. The Pfizer-Biontech vaccine will begin Monday. “

The Pfizer-BioNTech vaccine was first approved in the UK and UK residents began receiving the vaccine earlier this month.

WHAT VACCINE IS SAFE?

[ad_2]